FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4302012013> ?p ?o ?g. }

• W4302012013 endingPage "e0272372" @default.
• W4302012013 startingPage "e0272372" @default.
• W4302012013 abstract "Background The use of High-flow nasal cannula (HFNC) is increasing in admitted COPD-patients and could provide a step in between non-invasive ventilation (NIV) and standard oxygen supply. Recent studies demonstrated that HFNC is capable of facilitating secretion removal and reduce the work of breathing. Therefore, it might be of advantage in the treatment of acute exacerbations of COPD (AECOPD). No randomized trials have assessed this for admitted COPD-patients on a regular ward and only limited data from non-randomized studies is available. Objectives The aim of our study was to identify the reasons to initiate treatment with HFNC in a group of COPD-patients during an exacerbation, further identify those most likely to benefit from HFNC treatment and to find factors associated with treatment success on the pulmonary ward. Material and methods This retrospective study included COPD-patients admitted to the pulmonary ward and treated with HFNC from April 2016 until April 2019. Only patients admitted with severe acute exacerbations were included. Patients who had an indication for NIV-treatment where treated with NIV and were included only if they subsequently needed HFNC, e.g. when they did not tolerate NIV. Known asthma patients were excluded. Results A total of 173 patients were included. Stasis of sputum was the indication most reported to initiate HFNC-treatment. Treatment was well tolerated in 83% of the patients. Cardiac and vascular co-morbidities were significantly associated with a smaller chance of successful treatment (Respectively OR = 0.435; p = 0.013 and OR = 0.493;p = 0.035). Clinical assessment judged HFNC-treatment to be successful in 61% of the patients. Furthermore, in-hospital treatment with NIV was associated with a higher chance of HFNC failure afterwards (OR = 0.439; p = 0.045). Conclusion This large retrospective study showed that HFNC-treatment in patients with an AECOPD was initiated most often for sputum stasis as primary reason. Factors associated with improved outcomes of HFNC-treatment was the absence of vascular and/or cardiac co-morbidities and no need for in-hospital NIV-treatment." @default.
• W4302012013 created "2022-10-06" @default.
• W4302012013 creator A5004204265 @default.
• W4302012013 creator A5010156321 @default.
• W4302012013 creator A5044634343 @default.
• W4302012013 creator A5061070270 @default.
• W4302012013 creator A5078928711 @default.
• W4302012013 date "2022-10-05" @default.
• W4302012013 modified "2023-09-27" @default.
• W4302012013 title "High-flow nasal cannula oxygen therapy for admitted COPD-patients. A retrospective cohort study" @default.
• W4302012013 cites W1636646018 @default.
• W4302012013 cites W175847646 @default.
• W4302012013 cites W1835750185 @default.
• W4302012013 cites W1912936344 @default.
• W4302012013 cites W1920007087 @default.
• W4302012013 cites W1991318365 @default.
• W4302012013 cites W2004095802 @default.
• W4302012013 cites W201724846 @default.
• W4302012013 cites W2028976095 @default.
• W4302012013 cites W2048126670 @default.
• W4302012013 cites W2054504961 @default.
• W4302012013 cites W2063853377 @default.
• W4302012013 cites W2077485817 @default.
• W4302012013 cites W2091919008 @default.
• W4302012013 cites W2099266581 @default.
• W4302012013 cites W2110934109 @default.
• W4302012013 cites W2118357854 @default.
• W4302012013 cites W2124129697 @default.
• W4302012013 cites W2129289400 @default.
• W4302012013 cites W2131743829 @default.
• W4302012013 cites W2146020538 @default.
• W4302012013 cites W2148038715 @default.
• W4302012013 cites W2150613910 @default.
• W4302012013 cites W2158879735 @default.
• W4302012013 cites W2165229141 @default.
• W4302012013 cites W2171676943 @default.
• W4302012013 cites W2174167295 @default.
• W4302012013 cites W2217280470 @default.
• W4302012013 cites W2239720248 @default.
• W4302012013 cites W2405289598 @default.
• W4302012013 cites W2512322441 @default.
• W4302012013 cites W2577934311 @default.
• W4302012013 cites W2785858662 @default.
• W4302012013 cites W2794410306 @default.
• W4302012013 cites W2840379597 @default.
• W4302012013 cites W2907687349 @default.
• W4302012013 cites W2922848902 @default.
• W4302012013 cites W2924109498 @default.
• W4302012013 cites W2948064614 @default.
• W4302012013 cites W3007293603 @default.
• W4302012013 cites W3111623578 @default.
• W4302012013 cites W3120656392 @default.
• W4302012013 cites W3206825654 @default.
• W4302012013 cites W4210985264 @default.
• W4302012013 cites W4243610498 @default.
• W4302012013 cites W2799990319 @default.
• W4302012013 doi "https://doi.org/10.1371/journal.pone.0272372" @default.
• W4302012013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36197917" @default.
• W4302012013 hasPublicationYear "2022" @default.
• W4302012013 type Work @default.
• W4302012013 citedByCount "3" @default.
• W4302012013 countsByYear W43020120132023 @default.
• W4302012013 crossrefType "journal-article" @default.
• W4302012013 hasAuthorship W4302012013A5004204265 @default.
• W4302012013 hasAuthorship W4302012013A5010156321 @default.
• W4302012013 hasAuthorship W4302012013A5044634343 @default.
• W4302012013 hasAuthorship W4302012013A5061070270 @default.
• W4302012013 hasAuthorship W4302012013A5078928711 @default.
• W4302012013 hasBestOaLocation W43020120131 @default.
• W4302012013 hasConcept C126322002 @default.
• W4302012013 hasConcept C141071460 @default.
• W4302012013 hasConcept C142724271 @default.
• W4302012013 hasConcept C167135981 @default.
• W4302012013 hasConcept C168563851 @default.
• W4302012013 hasConcept C177713679 @default.
• W4302012013 hasConcept C2776301714 @default.
• W4302012013 hasConcept C2776780178 @default.
• W4302012013 hasConcept C2777014857 @default.
• W4302012013 hasConcept C2778074680 @default.
• W4302012013 hasConcept C2780334268 @default.
• W4302012013 hasConcept C2780630273 @default.
• W4302012013 hasConcept C2781069245 @default.
• W4302012013 hasConcept C42219234 @default.
• W4302012013 hasConcept C71924100 @default.
• W4302012013 hasConceptScore W4302012013C126322002 @default.
• W4302012013 hasConceptScore W4302012013C141071460 @default.
• W4302012013 hasConceptScore W4302012013C142724271 @default.
• W4302012013 hasConceptScore W4302012013C167135981 @default.
• W4302012013 hasConceptScore W4302012013C168563851 @default.
• W4302012013 hasConceptScore W4302012013C177713679 @default.
• W4302012013 hasConceptScore W4302012013C2776301714 @default.
• W4302012013 hasConceptScore W4302012013C2776780178 @default.
• W4302012013 hasConceptScore W4302012013C2777014857 @default.
• W4302012013 hasConceptScore W4302012013C2778074680 @default.
• W4302012013 hasConceptScore W4302012013C2780334268 @default.
• W4302012013 hasConceptScore W4302012013C2780630273 @default.
• W4302012013 hasConceptScore W4302012013C2781069245 @default.
• W4302012013 hasConceptScore W4302012013C42219234 @default.

• next